Ranavirus, family Iridoviridae), a pathogen also involved in mortalities of fish and reptiles. Experimental oral infection with FV3 in captive-raised adult wood frogs, Rana sylvatica (Lithobates sylvaticus), was performed as the first step in establishing a native North American animal model of ranaviral disease to study pathogenesis and host response. Oral dosing was successful; LD 50 was 10 2.93 (2.42-3.44) p.f.u. for frogs averaging 35 mm in length. Onset of clinical signs occurred 6-14 days post-infection (p.i.) (median 11 days p.i.) and time to death was 10-14 days p.i.
INTRODUCTION
Frog virus 3 (FV3), the type species of the genus Ranavirus (family Iridoviridae), was isolated more than 50 years ago (Granoff et al., 1966) but not until the beginning of the 1990s was it recognized as the pathogen responsible for high mortality epizootics in fish, amphibians and reptiles (Chinchar et al., 2009; Lesbarrères et al., 2012) . In 2008, infection with Ranavirus sp. became one of only two notifiable diseases of amphibians listed by the World Organization for Animal Health (2013) . Ranaviruses have been responsible for mass mortalities in wild and captive frogs and salamanders in north America, Asia, Australia and Europe (Gray et al., 2009) , and are currently the focus of intense research (Chinchar et al., 2009) . Experimental infections with various species and isolates of ranaviruses have been achieved through intraperitoneal injection (Tweedell & Granoff, 1968; Wolf et al., 1968) , immersion in viral suspension via water bath (Brunner et al., 2005; Harp & Petranka, 2006; Cullen & Owens, 2002) , exposure of cutaneous wounds to virus (Cunningham et al., 2007) and oral administration (Wolf et al., 1968; Hoverman et al., 2010) . Although the work of dozens of researchers, past and present, frequently focuses on experimental challenges with the original FV3 isolated in the 1960s (Granoff et al., 1966) , reported dosages vary, as do the species and developmental stage of the infected host. Research on FV3 is particularly relevant since many mortality events throughout the world are due to FV3 or FV3-like viruses (Chinchar, 2002) . Similarly to other viruses, the dose and route of infection are important determinants of FV3 pathogenicity (virulence, type and severity of lesions) (Brunner et al., 2005; Cullen & Owens, 2002; Cunningham et al., 2007) . Thus, the variability in experimental designs provides an abundance of valuable information but complicates comparisons and extrapolations. Amongst the multiple host species used in research, it is arguably in the African clawed frog, Xenopus laevis, that the host response of adult frogs to, and pathogenesis of, FV3 infection have been most extensively studied (Gantress et al., 2003; Robert et al., 2007 Robert et al., , 2011 . Adult X. laevis inoculated intraperitoneally with 10 7.7 p.f.u. of FV3 show only transitory signs of disease that are correlated with the presence of viral DNA in the kidney; signs disappear 2 weeks post-infection (p.i.) while virus becomes undetectable in most tissues 1 month p.i. when specific anti-FV3 IgY antibody production peaks (Gantress et al., 2003) although it may remain present in the kidney for several months and possibly result in excretion via urine-rich faeces (Gantress et al., 2003) . Unfortunately, X. laevis is a member of a family of frogs (Pipidae) not naturally present in North America or the rest of the northern hemisphere, which limits its regional relevance to the study of disease ecology in native amphibians. The anatomy and natural history of pipid frogs, which are restricted to tropical South America east of the Andes and to sub-Saharan Africa, differ significantly from those of frogs of the northern hemisphere: pipids are strictly aquatic and thus morphologically adapted to this environment with fully webbed feet, lateral-line organs, poorly developed to absent eyelids, no tongue and a diet composed mostly of zooplankton (Duellman & Trueb, 1994) . The validity of extrapolating findings on pipids to native North American frogs, particularly regarding mode of transmission, carrier states and pathophysiology, should be questioned since phylogeny, life history and type of habitat have been suggested to influence host susceptibility and response to ranavirus infection (Hoverman et al., 2011) . A better representative of the life history of the majority of frogs in the northern hemisphere and of those North American species in which the majority of mortalities have been reported since 1997 (Hoverman et al., 2011) is the family Ranidae, or true frogs. Ranid frogs are present across the entire northern hemisphere and extend the farthest north of any other amphibian species. The ranid anatomy, life history and reproductive strategy are those of the archetypical frog: mostly terrestrial (riparian, fossorial or occasionally arboreal), with a carnivorous/insectivorous diet, external fertilization, and egg laying and larval development in water (Duellman & Trueb, 1994) . Of the 29 North American species of ranids, at least 14 of which are known to be susceptible to ranavirus infection and disease , the wood frog, Rana sylvatica (Lithobates sylvaticus), was proposed as a focus for research by participants at the First International Symposium on Ranaviruses (Lesbarrères et al., 2012) . Researchers at the Symposium emphasized the need for an amphibian model for viral challenge experiments that allows for comparisons amongst studies and provides data to incorporate into ecological disease models, and thus selected the wood frog given its life history, high susceptibility to disease caused by FV3 and widespread distribution in North America which makes it sympatric with many other native species (Lesbarrères et al., 2012) . Experimental infections in wood frog tadpoles suggest that the susceptibility of the species to infection and mortality due to FV3 and FV3-like viruses is similar to, or slightly higher than, that of other sympatric North American species (Hoverman et al., 2011) . To our knowledge, no reports exist of experimental infection of adult wood frogs. Establishing a useful model of FV3 infection in wood frogs will allow for comparisons with what is known to occur in X. laevis and, more importantly, provide information on the pathogenesis of the infection in a species designated a representative of frogs commonly affected by the disease.
One of the first steps in establishing a native North American animal model to study ranavirus pathogenesis and host response to infection is the determination of the dose of virus necessary to cause mortality in 50 % of individuals: LD 50 . A known LD 50 allows for the design of virus challenge experiments with specific aims and for a meaningful comparison of results amongst studies. Along with a predetermined dose, it is necessary to find a route of administration that can mimic transmission in the wild, is easily employed and allows for the administration of precise dosages. As consumption of infected material (scavenging on infected carcasses) is a known route of ranavirus infection in wood frog tadpoles (Harp & Petranka, 2006) and since oral dosing allows for the administration of predetermined viral concentrations, the oral route is likely to fulfil those requirements.
Our overall aim was to propose parameters that can become the standard for future ranavirus North American frog models. Our specific objectives were to establish the LD 50 of FV3 virus in 1-year-old captive-raised wood frogs when administered orally, determine parameters potentially useful in disease modelling such as length of incubation period, median survival time (ST 50 ) and odds of death at a certain viral dose, establish whether shedding occurs in faeces and skin sheds and describe the clinicopathological changes resulting from infection.
RESULTS
The TCID 50 Fifteen frogs in the groups inoculated with FV3, henceforth referred to as 'fatally infected', were euthanized because of severe clinical signs (n56) or died (n59) from the FV3 infection (Fig. 2) . The remaining 19 frogs (including the four control frogs) exhibited no clinical signs, except for minimal petechiation of the hind feet (less than 10 petechiae in total, one frog in the 10 3.43 p.f.u. group), and mild depression but without loss of posture or reflexes (one frog in the 10 2.43 p.f.u. group), both on 14 days p.i. only. Clinical signs included regurgitation of food items, dazed stare or mild depression, severe depression with loss of withdrawal and/or righting reflex and widespread petechiation on the ventral surface of the skin (Table 1 ). An additional observation included as a clinical sign was the presence of a small (less than 0.5 cm in greatest diameter) ovoid pearly white bead found in the water dish of four of the fatally infected frogs but never produced by any of the survivors. It consisted of proteinaceous material (mucus) admixed with myriads of Gram-negative bacterial rods and a few rafts of cells (Fig. 1d-f) . Although the origin of this bead could not be unequivocally determined as its production was never observed, it was assumed to have formed in the colon of terminally diseased frogs based on its faeces-like shape and its histological similarity to material present in the lumen of necrotic segments of the distal digestive tract. (Fig. 2) . The fatally infected frogs averaged 32.9 mm with a median of 33.2 mm (range 29-37, mean 95 % CI 31.5-34.2). Although the frogs were not measured before the experiment, negligible growth would be expected to occur in 1-year-old animals over the short period of time the trial lasted (10-22 days), and thus measurements are assumed to reflect pre-infection lengths.
Even accounting for the difference in size between groups as a potential confounding variable, the size of the frog (SV length) at time of death had a significant effect on the onset of clinical signs and ST 50 (P values ,0.001 and 0.001, respectively): every millimetre increase in length resulted in a 6 % (95 % CI 3-9 %) delay in onset of signs and a 5 % delay in death (95 % CI 2-8 %) when dose was ¢10 2.43 p.f.u. The odds of dying increased 23-fold (P value50.017) for every tenfold increase in dose. The effect of size on the probability of death, if any, could not be statically assessed (the model would not converge), possibly due to the small sample size.
PCR for ranavirus DNA was positive in the skin and liver of all fatally infected frogs (15/15); in frogs that survived, skin and liver were consistently negative. PCR was negative in the skin and liver of all control frogs (Fig. 2) .
PCR for ranavirus DNA was positive in the faeces of 3/15 frogs (7, 8 and 11 days p.i.; 3-4.5 days before death) and in the skin sheds of 4/15 frogs (3, 4, 10 and 10 days p.i.; strongly positive 0-1.5 days prior to death) that died from FV3 infection (Table 1) . Collectively, 18 faeces and six skin sheds collected on 1-10 days p.i. from several of the 15 dead frogs yielded a negative PCR signal. All faeces and skin sheds collected pre-inoculation and 0-22 days p.i. from control frogs and inoculated frogs that did not develop severe clinical signs to warrant euthanasia were negative.
Gross lesions noted at necropsy were present only in fatally infected frogs and consisted of petechial/ecchymotic haemorrhages in skin (Fig. 1a, b) , free blood in oral cavity, focal to extensive haemorrhage in the wall of stomach and/ or intestine (Fig. 1c) , blood in faecal swab, petechiae in coelomic fat bodies or testicles and an air-filled stomach. Splenomegaly, subjectively determined in reference to the size of the spleen of control frogs, was noted both in fatally infected frogs and those that survived, but it was slightly more marked in mortalities (average 1.9 times larger than control) (Table 1, Fig. 3 ) than in survivors (average 1.4 times larger than control). Histological lesions were also restricted to fatally infected frogs and involved multiple tissues (Table 2 , Figs 4 and 5). Amongst the frogs that survived to the end of the trial there was some evidence of hyperplasia of haematopoietic tissue in the bone marrow and spleen, renal tubular regeneration or hyperplasia and nodular proliferation of lymphocytes in the wall of the urinary bladder and colonic submucosa. Immunohistochemical staining was performed in one frog from the nonexposed (control) group, two frogs in the group that received the highest dose (10 5.43 p.f.u.), the sole survivor in the group that received 10 3.43 p.f.u. dose and three frogs that survived, one from each of the lowest dose groups (10 2.43 , 10 1.43 and 10 0.43 p.f.u.) (Table 3) . Immunohistochemical staining for ranaviral antigen (cytoplasmic, usually as fine to coarse variably abundant granules) of the fatally infected frogs that received the highest dose demonstrated the presence of ranavirus antigen in and around areas of necrosis in various tissues (Table 3 ). In the frogs that survived, staining was observed in scattered single cells in the connective tissue of one or more tissues (Table 3 ). The morphology of the immunohistochemically stained cells found in survivors, and their location (rarely in parenchymal organs like kidney or pancreas and commonly in the submucosa of a luminal organ or wall of a cavity), suggest tissue macrophages. In nervous tissue (brain and peripheral nerves), testes, ovary, oviduct and abdominal adipose tissue no staining was detected in any of the frogs. None of the tissues from the non-exposed (control) frog stained immunohistochemically. Non-specific staining was negligible according to the antibody and conjugate internal controls.
DISCUSSION
Our results indicate that the oral LD 50 of FV3 in 1-year-old wood frogs averaging 35 mm of SV length is 10 2.93 (2. 42-3.44) p.f.u. per frog. Although wood frogs usually begin reproduction at 2 years of age (Duellman & Trueb, 1994) and our experimental subjects were only 1 year old, most were sexually mature (oogenesis or spermatogenesis evident histologically in 19/20 frogs examined) and thus representative of the anatomy and immunophysiology of adult individuals. Our findings can probably also apply to postmetamorphic juveniles as immune system maturation occurs at metamorphosis or soon afterwards (Robert & Ohta, 2009 Rgt, Regurgitation of food item; Brb, bacteria-rich mucous bead in water dish; MDpr, dazed stare or mild depression; SDpr, severe depression with loss of withdrawal or righting reflex; Ptc, petechiae in the ventral skin and/or limbs; Onst, first onset of clinical signs; PH-S, petechiae/haemorrhage in skin; B-Or, blood from oral cavity; PH-GI, petechiae/haemorrhage in wall of gastrointestinal tract; B-Fc, blood in faecal swab; PH-V, petechiae/haemorrhage in parenchymatous organs (a, fat bodies; b, testicles); AFS, air-filled stomach; Splx, proportional increase in size of spleen compared with age-matched control; NR, not recorded. *Death was recorded at time of observation except when a frog died overnight, in which case 0.5 of a day was deducted. DInterval between onset of clinical signs and time of death (ClS-Dth) of 0 indicates no signs detected on the previous check (,12 h earlier). dIndicates only weak positivity in PCR test for ranavirus DNA. (Maniero & Carey, 1997) . Although we conducted the experimental inoculation in early spring, a time when wood frogs are most likely to come in contact with infected carriers as they go to the ponds for mating (Brunner et al., 2004) , the temperature maintained during the experiment (average 21 u C) was higher than the environmental temperature would have been in the wild. Statistical models of disease incorporating any of our results as parameters must account for temperature and humidity differences in the habitat of the population of interest.
Based on our statistical model, dose of FV3 was the most important factor in the length of the incubation period, the survival time and the probability of dying. DProportion of frogs with a lesion out of all those examined (n59).
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death occurred approximately 15 % sooner per tenfold increase in dose. The lone survivor amongst the frogs that received a dose above the LD 50 was the largest of its group, while the frog that died in the group given a dose below the LD 50 was the smallest (Fig. 2) . This is probably a reflection of the crudeness of the estimate (both mortalities fall within the 95 % CI for the LD 50 dose) and the inherent variability in susceptibility of live animals to infection more than an indication that the size of the frog, as estimated by SV length, could exert an influence on survivability at a given viral concentration.
While there is no analytical or empirical evidence to support an influence of size on the probability of dying from a given dose of FV3, the incubation period and survival time may be lengthened slightly the larger the frog is. At a given dose, the onsets of clinical signs and death were delayed by approximately 6 % and 5 %, respectively, for each millimetre increase in size. Although the model supporting this finding is analytically strong and reflects what was observed in this trial, its predictive potential is very poor, particularly when applied to frogs outside the range of sizes included in this trial. For instance, the model predicts that a 51 mm frog would die 31 days p.i. if given 10 4.43 p.f.u. of FV3 but, based on infection of adult wood frogs of that size (unpublished data), this overestimates the ST 50 by 17-18 days, incorrectly doubling it. The poor predictive ability could be due to our small sample size or the occurrence of the observations for both events (clinical onset and death) during such a short time interval. The observed effect of size on the ST 50 and onset of clinical signs is probably an indirect reflection of the effect of dose: when a given dose is administered to two frogs of different sizes, the larger frog necessarily receives a smaller dose proportionally to its body size. This association suggests the need to distinguish between an absolute dose (p.f.u. in inoculum per frog) and a proportional dose (p.f.u. in inoculum mm 21 body size). Based on a logistic regression of our results, the proportional dose of FV3 in adult wood frogs would be calculated as 10 0.08 p.f.u. mm
21
; e.g. the LD 50 for a group of wood frogs averaging 50 mm in length would be close to 10 4.18 p.f.u. per frog. Future experimental infections will be required to test this hypothesis.
While the skin and liver of all frogs that died were positive for ranavirus DNA by PCR, tissues from all surviving frogs were negative. Although this could suggest that infection simply failed to establish in the surviving frogs, the difference in sampling times must be taken into account: 10-14 days p.i. for mortalities (positive frogs) and 22 days p.i. for survivors (negative frogs). The virus could either have been cleared by the time the survivors were sampled, indicating complete recovery with no carrier state, or simply been present in tissues other than those tested. This corresponds to what occurs in X. laevis frogs inoculated intraperitoneally with FV3 where the virus is undetectable in most tissues within 2 weeks of infection (Gantress et al., 2003) and in the kidney 20 days p.i. and resembles the negative PCR results found in the liver and blood of wild adult green frogs [Rana (Lithobates) clamitans] during a natural outbreak of FV3 (Forzán & Wood, 2013) . The immunohistochemical staining observed in cells in various tissues from surviving frogs, even in a 
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frog inoculated with the lowest dose, indicates that the frogs were infected but managed to control the infection and thus survived. The morphology of the immunohistochemically stained cells and their location are suggestive of tissue macrophages. The identity of these cells, whether the material is viable virus or simply segments of viral particles, how long the antigen remains in the surviving host cells (if indeed infected) and what role it plays in transmission is beyond the scope of this study, but the presence of ranavirus antigen in survivors suggests that even low doses of the virus are capable of causing an infection and that recovered animals may serve as asymptomatic carriers.
As stated before, differences in experimental designs of previous studies make comparisons and extrapolations difficult. For instance, X. laevis inoculated intraperitoneally with 10 7.7 p.f.u. of FV3 exhibited temporary signs of illness (anorexia, skin shedding and cutaneous erythema of the legs) during the first week p.i. (Gantress et al., 2003) . Although the erythema recorded for X. laevis may correspond to the petechiation observed in wood frogs in our study, it is impossible to compare the time to onset of clinical signs as the dates provided by Gantress et al. (2003) are imprecise. Regarding ST 50 , mortality of Cope's grey tree frog tadpoles [Hyla chrysoscelis, family Hylidae, found in the south-eastern United States (Dodd, 2013) ] exposed to water containing FV3 began 12 days p.i. and reached 66 % (Hoverman et al., 2010) , whereas mortality of tiger salamander tadpoles [Ambystoma tigrinum, family Ambysomatidae, found in southern Canada, the continental USA and north-eastern Mexico (Duellman & Trueb, 1994) ] also exposed to water containing FV3 began just under 20 days p.i. and reached 91 % (Brunner et al., 2005) . Although these results could suggest a difference in susceptibility between species, Cope's grey tree frogs were exposed to 10 3 p.f.u. ml 21 (10 6 p.f.u. l
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) for 3-21 days whereas salamanders were exposed to 10 5 p.f.u. ml 21 for 7 days. The differences in methodology make it impossible to determine whether time to death and mortality rate are due to inherent species differences or simply reflect a different infective dose. If the method of Reed & Muench (1938) is applied to the salamander data as reported by Brunner et al. (2005) (Table 1) , the LD 50 of FV3 equals 10 3.05 p.f.u. ml
: a dose very close to the concentration of FV3 that caused 66 % mortalities in Cope's grey tree frogs. Hoverman et al. (2010) , by using a consistent methodology, demonstrated that tadpoles of three different species [pickerel frog, Rana (Lithobates) palustris, Cope's grey tree frog, and eastern narrow-mouthed toad, Gastrophryne carolinensis] are not equally susceptible to mortality when exposed to FV3. The authors also concluded that oral inoculation of a known dose of FV3 (10 6 p.f.u.) both increased mean mortality rate and sped time to death when compared to water-bath exposure. However, as the same viral concentration used in the direct oral infection was diluted in a 1 l water bath, the different outcomes may actually reflect the effect of dose, not of route of infection (Hoverman et al., 2010) . Table 3 . Immunohistochemical staining in a subset of wood frogs, Rana sylvatica (Lithobates sylvaticus), inoculated orally with various doses of FV3 and one non-exposed (control) frog
The primary antibody used (anti-EHNV, epizootic haematopoietic necrosis virus) cross-reacts with FV3 (Ariel et al., 2010 
NE, Not examined.
M. J. Forzá n and others
The use of oral dosing, as opposed to the often used intraperitoneal injection, is a better approximation of what occurs under natural conditions (Gray et al., 2009 ). Exposure to virus-loaded water is thought to achieve infection via contact with oral or branchial mucosa (Gray et al., 2009) . Therefore, oral administration may be just as relevant in replicating natural exposure to viral particles in water bodies as is immersion in a water bath, and possibly more relevant for terrestrial species like the wood frog. Oral dosing allows for administration of relatively precise doses, and can be effected easily in most post-metamorphic frogs and even tadpoles of some species (Wolf et al., 1968; Hoverman et al., 2010) .
The positive PCR signal (ranavirus DNA) in faeces and skin sheds of frogs that died from infection suggests that both are potential sources of transmission, particularly in the last few days before death.
Gross and histological lesions present in frogs that died from FV3 infection resembled those reported in most other species infected with a Ranavirus sp. (Gray et al., 2009; Cullen & Owens, 2002; Cunningham et al., 2007; Kik et al., 2011) and involved primarily the haematopoietic cells (bone marrow, spleen, kidney and liver), renal glomeruli, and mucosal epithelium of the oral cavity, gastrointestinal tract and, to a lesser degree, urinary bladder. Necrosis of the colonic mucosa seemed to have been associated with an accumulation of mucus and bacterial overgrowth in the colon of some individuals, which was shed as a cohesive pearly white mass approximately 24 h prior to death. Whereas the main lesion reported in immunocompromised X. laevis infected with FV3 was necrosis of the epithelium of renal proximal tubules (Robert et al., 2005) , damage to the epithelium of the renal tubules in wood frogs was observed only in some individuals and it was often mild. Although there may be a true difference in the type of tissue targeted by FV3 in each species, the published histopathological images of FV3 infection in X. laevis appear to represent haematopoietic rather than tubular necrosis (Robert et al., 2005) . In some of the frogs that survived the infection, and particularly in the one survivor of the group that received 10 3.43 p.f.u. of FV3, there appeared to have been hyperplasia of bone marrow haematopoietic tissue, regeneration of renal tubules and formation of small clusters of lymphocytes in the colonic and urinary bladder mucosa, suggesting an activation of the immune system during infection. Supporting this interpretation is the lymphocytic (CD8) response to FV3 that occurs in X. laevis , but the precise mechanism of this response in wood frogs require further investigation.
The development and characterization of this ranaviruswood frog model is an important step to facilitate research of ranavirus infection in North American frogs. Oral inoculation, developed for this study, was easily performed and allowed for the administration of precise doses. Our results include environmental parameters, clinical signs, median survival time, probability of death at a given dose, viral shedding in faeces and skin sheds, gross and histological lesions and immunohistochemical staining results under controlled laboratory conditions. These findings provide transmission, infection and mortality estimates that could be incorporated into ranavirus disease models and facilitate the design of experiments to investigate the pathogenesis of ranavirus infection in North American frogs.
METHODS
Origin and housing of experimental subjects. Wood frog tadpoles were collected from an urban pond in Prince Edward Island, Canada, 1-2 weeks after hatching (17 May 2012) and housed in accordance with guidelines of the Canadian Council on Animal Care (CCAC, 2004; Fig. S1a, b) . Tadpoles (later frogs) were maintained at a fairly constant room temperature both before and during the experimental infection (overall average 21-22 uC). Humidity varied considerably and reflected the seasonal ambient temperature (overall average 41-56 %) (Supplementary Table S1 ). All mortalities (29/112 frogs that completed metamorphosis) that occurred in the months prior to the experiment were examined grossly and histologically for any lesions suggestive of a ranavirus infection since there is no reliable method to detect subclinical infection in live animals. As none of the mortalities had any histological evidence of a ranaviral infection, we assumed that the captive-raised animals were free of the virus. One year post-hatching (2 May 2013), the 34 frogs used in the experimental trial were placed in individual tanks and randomly assigned to an infection (n530, five frogs per dose of inoculum) or control group (n54). After 6 days of acclimation to their individual tanks, the frogs were inoculated with FV3.
FV3 culture. The virus stock used in this study, originally isolated in 1965 from a Northern leopard frog, Rana (Lithobates) pipiens (Granoff et al., 1966) , was grown by the authors in EPC (one passage) at room temperature (18-20 uC) (please refer to supplementary Methods). Titrations of viral stock were performed to determine median TCID 50 and p.f.u. following standard methods (Reed & Muench, 1938; Dulbecco & Vogt, 1954) . Calculation of LD 50 dose followed the method of Reed & Muench (1938) corroborated by a logistic regression.
Inoculation, termination and sample collection. On inoculation day, each frog was orally administered 50 ml of minimum maintenance medium (MEM supplemented with 2 % FBS and 1 % Antibiotic Antimycotic, Invitrogen) containing 0 (control group, n54), 10 0.43 , 10 1.43 , 10 2.43 , 10 3.43 , 10 4.43 or 10 5.43 p.f.u. of FV3 (infection groups, n55 per dose of inoculum) through a graded pipette (Fig. S1c) . The small volume of inoculum was chosen to avoid any regurgitation. Frogs were checked two or three times daily to record specific clinical signs. Faeces and skin sheds found in the water dish of control and inoculated frogs were collected opportunistically, frozen at 280 uC and later tested for ranavirus DNA by PCR. Upon every collection the water dish was disinfected and refilled with clean water. All handling started with the controls and continued through the infection groups from lowest to highest virus dose; equipment (i.e. plastic gloves, metal forceps) was disinfected with sodium hypochlorite (5 % bleach solution) after handling each frog or enclosure.
Euthanasia was performed at a predetermined end point [when frogs exhibited signs indicative of serious illness (Wright & Whitaker, 2001) that would have eventually resulted in death] instead of allowing death to occur naturally. Thus, euthanasia (by immersion in a 10 % solution of tricaine methanesulfonate, TMS; Syndel Laboratories) was performed when a frog exhibited two or more of the following signs: severely depressed appearance (head down and back legs extended with loss of normal upright posture and of withdrawal reflex), loss of righting reflex or presence of many petechial haemorrhages in the skin of the fore or hind feet, inner thighs or ventrum (Fig. 1a, b) . The FV3 ranavirus multidose trial infection of wood frogs
